{"id":"W2461531801","doi":"10.1200/jco.2012.30.27_suppl.104","title":"Safety of everolimus for women over age 65 with advanced breast cancer (BC): 12.5-month follow-up of BOLERO-2.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; University of Calgary","funders":"","keywords":"Medicine; Everolimus; Exemestane; Internal medicine; Adverse effect; Tolerability; Breast cancer; Rash; Placebo; Population; Aromatase inhibitor; Oncology; Cancer; Aromatase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00205879,0.00023472,0.002538828,0.000128976,0.00003238968,0.000002116812,0.0002221235,0.0003224842,0.0003665863],"category_scores_gemma":[0.00065615,0.000156938,0.0005213632,0.000157703,0.0004555427,0.000332458,0.00004942876,0.0006218717,0.000001385247],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004770109,"about_ca_system_score_gemma":0.001388533,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004304769,"about_ca_topic_score_gemma":0.0001292218,"domain_scores_codex":[0.9960862,0.0001799367,0.002485352,0.000200488,0.0005004822,0.0005474869],"domain_scores_gemma":[0.9934777,0.001576244,0.003331041,0.0003090318,0.0007618096,0.0005441589],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.2253658,0.002738126,0.2225039,0.0003261532,0.002274074,0.00006453985,0.001399678,0.0002618556,0.003054484,0.0001926666,0.0006513454,0.5411674],"study_design_scores_gemma":[0.05229303,0.01604263,0.7990797,0.0005410296,0.000576103,0.0003347017,0.0005813028,0.000016771,0.0005397185,0.0003806763,0.1294133,0.0002010611],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912322,0.00145861,0.001543341,0.002063935,0.001864294,0.0005428104,0.0001034294,0.00001163109,0.00117975],"genre_scores_gemma":[0.9873921,0.000677807,0.008397038,0.001106846,0.001518792,0.00003419975,0.000002901979,0.00004965981,0.0008206582],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5765758,"threshold_uncertainty_score":0.6399744,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05807774968586379,"score_gpt":0.4320381526482892,"score_spread":0.3739604029624254,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}